Anatara’s lead product is Detach, a natural, non-antibiotic oral medication used to treat and prevent gastrointestinal disease in livestock and humans. Unlike antibiotic medications, Detach will not cause antimicrobial resistance.
Anatara plans to launch Detach into the Australian market in 2017.
There is substantial market opportunity for Detach as the global demand for meat is rising, and authorities around the world have started to ban growth promoting antibiotics in animal production.
The global animal antibiotic market was valued at $4.63 billion in 2014.
Anatara has an exclusive option to licence Detach for worldwide commercialisation with Zoetis Inc, the world's largest producer of medicine and vaccinations for pets and livestock.
